Expert Opinion on Drug Metabolism and Toxicology

Aims & Scope

Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox.

Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome: Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data.

Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug.

The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.4
2024	3.90

SJR (SCImago Journal Rank)

Year	Value
2024	0.986

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	104

Journal Rank

Year	Value
2024	4944

Journal Citation Indicator

Year	Value
2024	1030

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction

  Citation: 1213

  Authors: Marcella, Geny M M, Ruben

• Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

  Citation: 675

  Authors: Satori A, Chad, Dimitrios, Vasilis

• Caco-2 cell permeability assays to measure drug absorption

  Citation: 495

  Authors: Richard B, Yongmei

• The Simcyp^®Population-based ADME Simulator

  Citation: 474

  Authors: Masoud, Steve, Kairui, Adrian, Geoffrey, Amin

• The Caco-2 cell monolayer: usefulness and limitations

  Citation: 421

  Authors: Huadong, Edwin CY, Shanjun, Yimin, K Sandy

• Antisense oligonucleotide pharmacokinetics and metabolism

  Citation: 272

  Authors: Richard S

• Species differences in drug transporters and implications for translating preclinical findings to humans

  Citation: 265

  Authors: Xiaoyan, Kelly, Raymond

• Zebrafish assays for drug toxicity screening

  Citation: 247

  Authors: Amy L

• The influence of gut microbiota on drug metabolism and toxicity

  Citation: 232

  Authors: Houkai, Jiaojiao, Wei

• Cytochrome P450 variations in different ethnic populations

  Citation: 229

  Authors: Joseph, Donald

---